Business & Regulation Business Practice, Packaging, Standards & Regulation, Trends & Forecasts

Let’s Get Ready to Serialize!

One third of pharma companies claim they are “very ready” for the upcoming serialization deadlines. But are they really?

James Strachan | 04/11/2018

The US and EU serialization deadlines are both less than a year away, with the EU Falsified Medicines (FMD) Directive coming into force on February 9, 2019 and the US Drug Supply Chain Security Act (DSCSA) coming into force on November 27, 2018 – the latter already having been delayed by one year. So how prepared are pharma companies?

Tracelink surveyed 660 companies across segments of the supply chain, including 174 drugmakers, to find out. In their Global Drug Supply, Safety and Traceability Report, they found that only one-third of respondents believe they are “very ready” for serialization. The data also revealed that no single company has actually completed all the basic steps for serialization readiness. According to the authors, the survey proves “that the companies who feel very ready are considerably ‘less ready’ than they think.”

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Business & Regulation Business Practice, Packaging, Standards & Regulation, Trends & Forecasts

TraceLink, “TraceLink Publishes Full Analysis from the Global Drug Supply, Safety and Traceability Report, Industry’s Largest Survey on Life Science Companies’ Readiness for Serialization Deadlines” (2018). Available at:
bit.ly/2JvuQfP. Accessed April 10, 2018.

James Strachan

Over the course of my Biomedical Sciences degree it dawned on me that my goal of becoming a scientist didn’t quite mesh with my lack of affinity for lab work. Thinking on my decision to pursue biology rather than English at age 15 – despite an aptitude for the latter – I realized that science writing was a way to combine what I loved with what I was good at.

From there I set out to gather as much freelancing experience as I could, spending 2 years developing scientific content for International Innovation, before completing an MSc in Science Communication. After gaining invaluable experience in supporting the communications efforts of CERN and IN-PART, I joined Texere – where I am focused on producing consistently engaging, cutting-edge and innovative content for our specialist audiences around the world.